1. Home
  2. YUMC vs BMRN Comparison

YUMC vs BMRN Comparison

Compare YUMC & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yum China Holdings Inc.

YUMC

Yum China Holdings Inc.

N/A

Current Price

$43.74

Market Cap

14.8B

ML Signal

N/A

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

N/A

Current Price

$66.42

Market Cap

13.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YUMC
BMRN
Founded
1987
1996
Country
China
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.8B
13.0B
IPO Year
2016
1999

Fundamental Metrics

Financial Performance
Metric
YUMC
BMRN
Price
$43.74
$66.42
Analyst Decision
Buy
Analyst Count
0
18
Target Price
N/A
$88.22
AVG Volume (30 Days)
1.3M
2.2M
Earning Date
04-29-2026
05-04-2026
Dividend Yield
2.38%
N/A
EPS Growth
7.73
N/A
EPS
1.57
0.77
Revenue
$11,797,000,000.00
$1,313,646,000.00
Revenue This Year
$9.42
$15.02
Revenue Next Year
$5.86
$12.23
P/E Ratio
$27.89
$86.55
Revenue Growth
4.37
17.62
52 Week Low
$40.15
$49.26
52 Week High
$58.39
$70.98

Technical Indicators

Market Signals
Indicator
YUMC
BMRN
Relative Strength Index (RSI) 35.97 56.83
Support Level $42.46 $58.03
Resistance Level $44.80 $70.98
Average True Range (ATR) 1.02 1.56
MACD -0.59 -0.34
Stochastic Oscillator 8.47 46.31

Price Performance

Historical Comparison
YUMC
BMRN

About YUMC Yum China Holdings Inc.

Yum China is the largest restaurant operator in China, with over 18,000 locations and USD 12 billion in systemwide sales as of 2025. It generates revenue primarily from its own restaurants and franchise fees. While KFC and Pizza Hut are its flagship brands, Yum China's portfolio also includes Little Sheep, Taco Bell, Huang Ji Huang, and Lavazza.As a trademark licensee of Yum Brands, Yum China pays 3% of KFC and Pizza Hut's systemwide sales to its former parent, from which it spun off in 2016. However, even before the separation, Yum China was granted substantial autonomy, giving its Chinese leadership decision-making authority over menu, supply chain, and marketing—an unusual practice for Western chains at the time.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: